Latest Information Update: 27 Sep 2016
At a glance
- Originator ERYtech Pharma
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 12 Sep 2016 Early research in Cancer in France (unspecified route) (ERYtech pipeline, September 2016) before September 2016